U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
LUMILIXIMAB
INN   MART.   WHO-DD  
INN  
Preferred Name English
GOMILIXIMAB
USAN  
USAN  
Official Name English
LUMILIXIMAB [MART.]
Common Name English
Lumiliximab [WHO-DD]
Common Name English
lumiliximab [INN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN IMMUNOGLOBULIN E RECEPTOR TYPE II) (HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .KAPPA.-CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN IMMUNOGLOBULIN E RECEPTOR TYPE II) (HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .KAPPA.-CHAIN, DIMER
Common Name English
ST-152
Code English
PRIMATIZED ANTI-CD23
Common Name English
IDEC-152
Code English
GOMILIXIMAB [USAN]
Common Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/08/528
Created by admin on Mon Mar 31 18:36:22 GMT 2025 , Edited by admin on Mon Mar 31 18:36:22 GMT 2025
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 18:36:22 GMT 2025 , Edited by admin on Mon Mar 31 18:36:22 GMT 2025
FDA ORPHAN DRUG 160502
Created by admin on Mon Mar 31 18:36:22 GMT 2025 , Edited by admin on Mon Mar 31 18:36:22 GMT 2025
Code System Code Type Description
EVMPD
SUB128912
Created by admin on Mon Mar 31 18:36:22 GMT 2025 , Edited by admin on Mon Mar 31 18:36:22 GMT 2025
PRIMARY
INN
8443
Created by admin on Mon Mar 31 18:36:22 GMT 2025 , Edited by admin on Mon Mar 31 18:36:22 GMT 2025
PRIMARY
FDA UNII
8Z13S29R5A
Created by admin on Mon Mar 31 18:36:22 GMT 2025 , Edited by admin on Mon Mar 31 18:36:22 GMT 2025
PRIMARY
CAS
357613-86-6
Created by admin on Mon Mar 31 18:36:22 GMT 2025 , Edited by admin on Mon Mar 31 18:36:22 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109151
Created by admin on Mon Mar 31 18:36:22 GMT 2025 , Edited by admin on Mon Mar 31 18:36:22 GMT 2025
PRIMARY
SMS_ID
100000154450
Created by admin on Mon Mar 31 18:36:22 GMT 2025 , Edited by admin on Mon Mar 31 18:36:22 GMT 2025
PRIMARY
USAN
OO-24
Created by admin on Mon Mar 31 18:36:22 GMT 2025 , Edited by admin on Mon Mar 31 18:36:22 GMT 2025
PRIMARY
WIKIPEDIA
Lumiliximab
Created by admin on Mon Mar 31 18:36:22 GMT 2025 , Edited by admin on Mon Mar 31 18:36:22 GMT 2025
PRIMARY
DRUG BANK
DB06162
Created by admin on Mon Mar 31 18:36:22 GMT 2025 , Edited by admin on Mon Mar 31 18:36:22 GMT 2025
PRIMARY
NCI_THESAURUS
C26448
Created by admin on Mon Mar 31 18:36:22 GMT 2025 , Edited by admin on Mon Mar 31 18:36:22 GMT 2025
PRIMARY
ACTIVE MOIETY
GOMILIXIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966